Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.

Autor: Gamez, Monica1 (AUTHOR) mg14606@bristol.ac.uk, Elhegni, Hesham E.1 (AUTHOR), Fawaz, Sarah1 (AUTHOR), Ho, Kwan Ho2 (AUTHOR), Campbell, Neill W.2 (AUTHOR), Copland, David A.3 (AUTHOR), Onions, Karen L.1 (AUTHOR), Butler, Matthew J.1 (AUTHOR), Wasson, Elizabeth J.1 (AUTHOR), Crompton, Michael1 (AUTHOR), Ramnath, Raina D.1 (AUTHOR), Qiu, Yan1 (AUTHOR), Yamaguchi, Yu4 (AUTHOR), Arkill, Kenton P.5 (AUTHOR), Bates, David O.5 (AUTHOR), Turnbull, Jeremy E.6 (AUTHOR), Zubkova, Olga V.7 (AUTHOR), Welsh, Gavin I.1 (AUTHOR), Atan, Denize3,8 (AUTHOR), Satchell, Simon C.1 (AUTHOR)
Zdroj: Cardiovascular Diabetology. 2/1/2024, Vol. 23 Issue 1, p1-17. 17p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje